Report Code: A14926 | Pages: NA | Mar 2023 | 562 Views | ||
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Phelan-mcdermid Syndrome Market
Request Now !Phelan-McDermid syndrome (PMS) is also known as 22q13 Deletion syndrome. It is a genetic condition that is caused by a variance of the SHANK3 gene or a deletion (a missing piece) of genetic material that causes many different but related symptoms. The genetic changes that cause PMS vary from person to person and can occur randomly (de novo) or be inherited from a parent who carries a related genetic change. The most common characteristics found in those with PMS are intellectual disability of varying degrees, delayed or absent speech, symptoms of autism spectrum disorder, low muscle tone, motor delays, and epilepsy. There is currently no cure or treatment specifically for PMS.
Â
COVID-19 scenario analysis
COVID-19 has affected almost all aspects of our lives. Â For individuals receiving applied behavior analysis (ABA) therapy or other such therapies for treatment of phelan-mcdermid syndrome require physical meeting but the pandemic has created significant barriers, with a particular impact on educational and social engagement. Prior to the pandemic, these individuals obtained behavioral treatment face-to-face with an ABA therapist, whether in their own home or in a clinical setting. Recently, due to COVID-19, the use of remote technology and telehealth options has become increasingly prevalent to provide ABA services to individuals and families. Research published in the Journal of Applied Behavior Analysis shows that the use of telehealth to implement behavior analytic services has shown positive outcomes, as reported by both practitioners and caregivers. Some challenges with teletherapy include limited access to technology, maintaining privacy, and controlling the therapy environment which may hinder the growth of Phelan-McDermid syndrome treatment market upto certain extent.
Top impacting factors: market scenario analysis, trends, drivers and impact analysis
Rise in the prevelance of genetic disorders is escalating the growth of phelan-mcdermid syndrome market. For instance, based on limited statistical analysis data published by National organization for rare disorders, the occurrence of of phelan-mcdermid syndrome rate has been estimated to fall in the range of 2.5-10 per million births. The increase in technological advancements in the diagnostics techniques and rise in the incidences of chemical modifications in gene or the DNA accelerate the market growth. Additionally, rise in R&D and healthcare expenditure will boost the growth of the market in the forecast period. On the other hand lack of awareness and high cost associated with the treatment of phelan-mcdermid syndrome expected to hinder the growth.
Key benefits of the report
Questions answered in the phelan-mcdermid syndrome market report
Phelan-McDermid Syndrome Market: Global Opportunity Analysis and Industry Forecast, 2021–2030 Report Highlights
Aspects | Details |
---|---|
By Diagnosis |
|
By Treatment |
|
By End User |
|
By Region |
|
Key Market Players | Cellcentric, CELGENE CORPORATION, EpiGentek group inc., Business wire inc.,, Oryzon genomics, Astex Pharmaceutucals, Base genomics |
Loading Table Of Content...
Start reading.
This Report and over 19,609+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers